Hormonal factors and the risk of invasive ovarian cancer: a population-based case-control study

被引:111
作者
Pike, MC [1 ]
Pearce, CL [1 ]
Peters, R [1 ]
Cozen, W [1 ]
Wan, P [1 ]
Wu, AH [1 ]
机构
[1] Univ So Calif, Kenneth Norris Jr Comprehens Canc Ctr, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA
关键词
ovarian cancer; parity; estrogen therapy; oral contraceptives;
D O I
10.1016/j.fertnstert.2004.03.013
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: To examine the influence of hormone-related factors on the risk of invasive epithelial ovarian cancer (ovarian cancer). Design: Population-based case-control study using in-person interviews. Setting: Academic department of preventive medicine. Patient(s): Four hundred seventy-seven ovarian cancer patients and 660 controls. Intervention(s): None. Main Outcome Measure(s): Numbers of and ages at births, oral contraceptive use, and use of menopausal hormone therapy. Result(s): Compared with nulliparous women, women whose only (last) birth was after age 35 years had an estimated 51% (95% confidence interval: 21%-70%) reduction in risk. If this birth occurred earlier, the reduction in risk was progressively less. Additional (earlier) births reduced the risk further. Oral contraceptive use also reduced risk. Increased body mass index increased risk, but this effect was confined to localized disease and is likely to be a diagnostic bias, as a consequence of other problems associated with being overweight and in itself having no etiological significance. Conclusion(s): If the major protective effect of a late birth can be confirmed, our most challenging task will be to understand the mechanism to develop a chemoprevention approach to exploit this finding.
引用
收藏
页码:186 / 195
页数:10
相关论文
共 47 条
[1]  
[Anonymous], 1987, NEW ENGL J MED, V316, P650
[2]  
BRESLOW NE, 1980, STATISTICAL METHODS, V1, P32
[3]  
CASAGRANDE JT, 1979, LANCET, V2, P170
[4]   A meta-analysis of estrogen replacement therapy and risk of epithelial ovarian cancer [J].
Coughlin, SS ;
Giustozzi, A ;
Smith, SJ ;
Lee, NC .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 2000, 53 (04) :367-375
[5]  
CRAMER DW, 1983, JNCI-J NATL CANCER I, V71, P711
[6]  
DICKEY RP, 1976, OBSTET GYNECOL, V47, P106
[7]   The cell of origin of ovarian epithelial tumors and the ovarian surface epithelium dogma: Does the emperor have no clothes? [J].
Dubeau, L .
GYNECOLOGIC ONCOLOGY, 1999, 72 (03) :437-442
[8]   Height, body mass index, and ovarian cancer: A follow-up of 1.1 million Norwegian women [J].
Engeland, A ;
Tretli, S ;
Bjorge, T .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (16) :1244-1248
[9]   Obesity, weight gain, and ovarian cancer [J].
Fairfield, KM ;
Willett, WC ;
Rosner, BA ;
Manson, JE ;
Speizer, FE ;
Hankinson, SE .
OBSTETRICS AND GYNECOLOGY, 2002, 100 (02) :288-296
[10]  
Fathalla M F, 1972, Obstet Gynecol Surv, V27, P751, DOI 10.1097/00006254-197211000-00001